LIN28B promotes colon cancer migration and recurrence

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Pang, Minghui ^a   Wu, Gang ^a   Hou, Xiaolin ^a   Hou, Nengyi ^a   Liang, Liqin ^a   Jia, Guiqing ^a   Shuai, Ping ^a   Luo, Bin ^a   Wang, Kang ^a   Li, Guoxin ^b  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIPLATIN; ANTINEOPLASTIC AGENT; LIN28B PROTEIN, HUMAN; PLATINUM COMPLEX; RNA BINDING PROTEIN;

ADULT; ARTICLE; CACO 2 CELL LINE; CANCER CELL LINE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; GENE; GENE OVEREXPRESSION; GENETIC CORRELATION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIN28B GENE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SW480 CELL LINE; TISSUE MICROARRAY; TUMOR RECURRENCE; UPREGULATION; CELL MOTION; COLONIC NEOPLASMS; DRUG EFFECTS; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; REFERENCE VALUE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; FEMALE; HCT116 CELLS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; REFERENCE VALUES; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 84910150068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109169     Document Type: Article

References (27)

1. Moss EG, Lee RC, Ambros V (1997) The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88: 637-646.
2. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, et al. (2006) Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384: 51-61.
3. Viswanathan SR, Daley GQ, Gregory RI (2008) Selective blockade of microRNA processing by Lin28. Science 320: 97-100.
4. Heo I, Joo C, Cho J, Ha M, Han J, et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276-284.
5. Zhong X, Li N, Liang S, Huang Q, Coukos G, et al. (2010) Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J Biol Chem 285: 41961-41971.
6. King CE, Wang L, Winograd R, Madison BB, Mongroo PS, et al. (2011) LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 30: 4185-4193.
7. Dansranjavin T, Krehl S, Mueller T, Mueller LP, Schmoll HJ, et al. (2009) The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Cell Cycle 8: 916-924.
8. Pan L, Gong Z, Zhong Z, Dong Z, Liu Q, et al. (2011) Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Mol Cell Biochem 355: 257-263.
9. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, et al. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41: 843-848.
10. Helland A, Anglesio MS, George J, Cowin PA, Johnstone CN, et al. (2011) Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One 6: e18064.
11. Cotterman R, Knoepfler PS (2009) N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One 4: e5799.
12. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, et al. (2009) Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 106: 3384-3389.
13. Rothberg PG (1987) The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli. Semin Surg Oncol 3: 152-158.
14. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
15. Akao Y, Nakagawa Y, Naoe T (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906.
16. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, et al. (2011) LIN28B promotes colon cancer progression and metastasis. Cancer Res 71: 4260-4268.
17. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, et al. (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7: 1-9.
18. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
19. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
20. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
21. Ji J, Wang XW (2010) A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. J Hepatol 53: 974-975.
22. Guo J, Li ZC, Feng YH (2009) Expression and activation of the reprogramming transcription factors. Biochem Biophys Res Commun 390: 1081-1086.
23. Jeong SH, Wu HG, Park WY (2009) LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 41: 912-918.
24. Jeanteur P (1998) [The role of APC in colonic cancerogenesis: zeroing in on Myc]. Bull Cancer 85: 925-928.
25. Panduro CA, Lima GG, Villalobos JJ (1993) [Molecular genetics of colorectal cancer and carcinogenesis]. Rev Invest Clin 45: 493-504.
26. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370: 2020-2029.
27. Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, et al. (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27: 872-877.